Rite Aid (RAD) Reports Wider-Than-Expected Q2 Loss; Guides Lower
More News related to RAD
- Rite Aid Expands Its Own Exclusive Rx Suncare Line with Rx Suncare Sport SPF 70 and Rx Suncare HairGuard
- Rite Aid Customers and Associates Donate More than $765,000 for Haiti Earthquake Relief Efforts
- Zoes Kitchen Implements Radiant Systems Point-of-Sale Technology
- Chris Hall Named Rite Aid Senior Vice President, Pharmacy Business Development
- Rite Aid Reports 2.1 Percent Same Store Sales Decrease for January
More News related to Earnings
- HNI Corporation (HNI) Tops Q1 EPS by 2c; Revs Light
- Team Health (TMH) Reports Mixed Q4 Results
- Baidu (BIDU) Blows the Lid Off Q4, Shares Jump
- Aspen Insurance (AHL) Posts Q4 adj.-EPS of $1.44, Tops Views
- Acadia Realty Trust (AKR) Misses Q4 FFO by 1c; Guides Below for FY10
Rite Aid Corp. (NYSE: RAD) reports Q2 loss of $0.27, versus the consensus of a $0.15 loss. Revenues came in at $6.5 billion, versus the consensus of $6.51 billion.
Rite Aid sees FY loss of $0.56-$0.67, versus the consensus of a $0.51 loss. Sees FY sales of $26-$26.5 billion, versus the consensus of $26.7 billion.
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores. Its retail stores primarily provide pharmacy services.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.02Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
